How to Safeguard the Ureter and Repair Surgical Injury Under Certain Circumstances, Ureteral Injury May Not Only Be Likely—It Is Unavoidable
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Urology Services in the ASC
Urology Services in the ASC Brad D. Lerner, MD, FACS, CASC Medical Director Summit ASC President of Chesapeake Urology Associates Chief of Urology Union Memorial Hospital Urologic Consultant NFL Baltimore Ravens Learning Objectives: Describe the numerous basic and advanced urology cases/lines of service that can be provided in an ASC setting Discuss various opportunities regarding clinical, operational and financial aspects of urology lines of service in an ASC setting Why Offer Urology Services in Your ASC? Majority of urologic surgical services are already outpatient Many urologic procedures are high volume, short duration and low cost Increasing emphasis on movement of site of service for surgical cases from hospitals and insurance carriers to ASCs There are still some case types where patients are traditionally admitted or placed in extended recovery status that can be converted to strictly outpatient status and would be suitable for an ASC Potential core of fee-for-service case types (microsurgery, aesthetics, prosthetics, etc.) Increasing Population of Those Aged 65 and Over As of 2018, it was estimated that there were 51 million persons aged 65 and over (15.63% of total population) By 2030, it is expected that there will be 72.1 million persons aged 65 and over National ASC Statistics - 2017 Urology cases represented 6% of total case mix for ASCs Urology cases were 4th in median net revenue per case (approximately $2,400) – behind Orthopedics, ENT and Podiatry Urology comprised 3% of single specialty ASCs (5th behind -
Ureterolysis.Pdf
Information about your procedure from The British Association of Urological Surgeons (BAUS) This leaflet contains evidence-based information about your proposed urological procedure. We have consulted specialist surgeons during its preparation, so that it represents best practice in UK urology. You should use it in addition to any advice already given to you. To view the online version of this leaflet, type the text below into your web browser: http://www.baus.org.uk/_userfiles/pages/files/Patients/Leaflets/Ureterolysis.pdf Key Points • Retroperitoneal fibrosis (RPF), also known as chronic periaortitis, forms at the back of your abdominal (tummy) cavity and can block your ureters (the tubes that carry urine from your kidneys to your bladder) • Ureterolysis is used to free your ureters from the blockage caused by the RPF • In most patients, the procedure involves open surgery through a long incision in your abdomen (tummy) but it can sometimes be done by laparoscopic (keyhole) surgery • To prevent further obstruction, we wrap your ureters in omentum (the fatty envelope inside your abdomen) or in a synthetic material • The procedure is usually reserved for patients in whom medical treatment has been unsuccessful • Care of patients with RPF is multi-disciplinary with physicians, expert surgeons and other specialists collaborating in your care What does this procedure involve? Freeing your ureters from scar tissue at the back of your abdomen to relieve the blockage and restore urine drainage from your kidneys. To prevent recurrence, we wrap your ureters in omentum (a sheet of fatty tissue found in your abdomen); if your omentum has been removed or is too small to use, we may wrap the ureters in a synthetic material. -
Robot-Assisted Laparoscopic Ureterolysis: Case Report and Literature Review of the Minimally Invasive Surgical Approach Ste´Fanie A
CASE REPORT Robot-Assisted Laparoscopic Ureterolysis: Case Report and Literature Review of the Minimally Invasive Surgical Approach Ste´fanie A. Seixas-Mikelus, MD, Susan J. Marshall, MD, D. Dawon Stephens, DO, Aaron Blumenfeld, MD, Eric D. Arnone, BA, Khurshid A. Guru, MD ABSTRACT INTRODUCTION Objectives: To evaluate our case of robot-assisted ureter- Ureteral obstruction secondary to extrinsic compression re- olysis (RU), describe our surgical technique, and review sults from both benign and malignant processes. Retroperi- the literature on minimally invasive ureterolysis. toneal fibrosis (RPF) and ureteral endometriosis (UE) are 2 uncommon conditions that cause ureteral obstruction.1–25 Methods: One patient managed with robot-assisted ure- terolysis for idiopathic retroperitoneal fibrosis was identi- First described in 1905 by Albarran and then by Ormond fied. The chart was analyzed for demographics, operative in 1948, RPF is a chronic inflammatory process character- parameters, and immediate postoperative outcome. The ized by deposition of dense fibrous tissue within the surgical technique was assessed and modified. Lastly, a retroperitoneum.26–28 Possible causes of RPF include med- review of the published literature on ureterolysis managed ications, infections, malignancy, inflammatory conditions, with minimally invasive surgery was performed. trauma, prior surgeries, and radiation therapy. About two- thirds of cases are considered idiopathic.10,25 Results: One patient underwent robot-assisted ureteroly- sis at our institution in 2 separate settings. Operative time Endometriosis, defined by the ectopic presence of endo- (OR) decreased from 279 minutes to 191 minutes. Esti- metrium, is another entity that can cause ureteral obstruc- mated blood loss (EBL) was less than 50mL. The patient tion. -
EAU Guidelines on Urinary Incontinence in Adults
EAU Guidelines on Urinary Incontinence in Adults F.C . Burkhard (Chair), J.L.H.R. Bosch, F. Cruz, G.E. Lemack, A.K. Nambiar, N. Thiruchelvam, A. Tubaro Guidelines Associates: D. Ambühl, D.A. Bedretdinova, F. Farag, R. Lombardo, M.P. Schneider © European Association of Urology 2018 TABLE OF CONTENTS PAGE 1. INTRODUCTION 8 1.1 Aim and objectives 8 1.1.1 The elderly 8 1.2 Panel composition 8 1.3 Available publications 8 1.4 Publication history 9 1.4.1 Summary of changes. 9 2. METHODS 11 2.1 Introduction 11 2.2 Review 11 2.3 Future goals 11 3. DIAGNOSTIC EVALUATION 11 3.1 History and physical examination 11 3.2 Patient questionnaires 12 3.2.1 Questions 12 3.2.2 Evidence 12 3.2.3 Summary of evidence and recommendations for patient questionnaires 13 3.3 Voiding diaries 14 3.3.1 Question 14 3.3.2 Evidence 14 3.3.3 Summary of evidence and recommendations for voiding diaries 14 3.4 Urinalysis and urinary tract infection 14 3.4.1 Question 14 3.4.2 Evidence 14 3.4.3 Summary of evidence and recommendations for urinalysis 15 3.5 Post-void residual volume 15 3.5.1 Question 15 3.5.2 Evidence 15 3.5.3 Summary of evidence and recommendations for post-void residual 15 3.6 Urodynamics 15 3.6.1 Question 16 3.6.2 Evidence 16 3.6.2.1 Variability 16 3.6.2.2 Diagnostic accuracy 16 3.6.2.3 Question 16 3.6.2.4 Evidence 16 3.6.2.5 Question 16 3.6.2.6 Evidence 16 3.6.2.7 Question 17 3.6.2.8 Evidence 17 3.6.2.9 Question 17 3.6.2.10 Evidence 17 3.6.3 Summary of evidence and recommendations for urodynamics 17 3.6.4 Research priority 18 3.7 Pad testing 18 3.7.1 Questions 18 3.7.2 Evidence 18 3.7.3 Summary of evidence and recommendations for pad testing 18 3.7.4 Research priority 18 3.8 Imaging 18 3.8.1 Questions 19 3.8.2 Evidence 19 3.8.3 Summary of evidence and recommendations for imaging 19 3.8.4 Research priority 19 2 URINARY INCONTINENCE IN ADULTS - LIMITED UPDATE MARCH 2018 4. -
Invasive Treatments for Urinary Incontinence
Cigna Medical Coverage Policy Effective Date .......................... 12/15/2013 Subject Invasive Treatments for Next Review Date .................... 12/15/2014 Coverage Policy Number ................. 0365 Urinary Incontinence Table of Contents Hyperlink to Related Coverage Policies Coverage Policy .................................................. 1 Biofeedback General Background ........................................... 2 Botulinum Therapy Coding/Billing Information ................................. 15 Electrical Stimulators References ........................................................ 16 Extracorporeal Electromagnetic Stimulation for Urinary Incontinence Injectable Bulking Agents for Urinary Conditions and Fecal Incontinence Physical Therapy Sacral Nerve Stimulation for Urinary Voiding Dysfunction and Fecal Incontinence INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna companies. Coverage Policies are intended to provide guidance in interpreting certain standard Cigna benefit plans. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage Policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a Coverage Policy. In the event of a conflict, a customer’s benefit plan document -
Contd... Supplementary Table 1: Contd
Supplementary Table1: Illustrates the main studies with ureteral endometriosis and their characteristics Author/year Journal Type of Number of Mean Ureteral Histological Management, n (%) study cases (n) age localization, n (%) type, n (%) Huang et al./2017 J Obstet RS 46 37.07 26 (56.5%) left, 22 (47.8%) 11 ureterolysis (23.9%), 28 (60.9%) Gynaecol Res 16 (34.8%) right, intrinsic, ureteroneocystostomy, 4 (8.7%) 4 (8.7%) bilateral 24 (52.2%) end‑to‑end ureteral anastomosis, extrinsic 3 (6.5%) nephrectomy Freire et al./2017 Urology RS 17 38 35.7% left, 14.3% 14.3% extrinsic, 7 distal ureterectomy, right, 10.7% bilateral 14.3% intrinsic 5 distal ureterectomy, and reimplantation (4 Lich‑Gregoir and 1 Lich‑Gregoir with psoas hitch), 3 ureteroureterostomy, 2 laparoscopic nephrectomy Kanno et al./2017 The Journal CR 1 25 100% right NR Laparoscopic segmental ureteral of Minimally resection and submucosal Invasive tunneling ureteroneocystostomy Gynecology with a psoas hitch and Boari flap Darwish et al./2017 J Minim RS 42 34.8 8 (19%) bilateral, 54.5% intrinsic 78% ureterolysis, 8% ureteral Invasive 17 (40.5%) right, resection followed by Gynecol 17 (40.5%) left end‑to‑end anastomosis, 14% ureteral resection and ureteroneocysostomy Alves et al./2017 J Minim RS 198 NR 7 (25%) left, 9 (32.1%) 76.9% intrinsic 100% ureterolysis, 6.06% Invasive right, 12 (42.9%) ureteral resection followed by Gynecol bilateral end‑to‑end anastomosis, 1 (0.5%) ureteroneocystostomy with Boari flap Abo et al./2016 Journal de RS 13 36 NR NR 11 (84.7%) advanced ureterolysis -
Urological Complications in Renal Transplantation
Henry Ford Hospital Medical Journal Manuscript 2015 Urological Complications in Renal Transplantation Riad N. Farah Richard Klugo Thomas Mertz Joseph C. Cerny Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Henry Ford Hosp Med Journal Vol 26, No 3, 1978 Urological Complications in Renal Transplantation Riad N. Farah, MD,* Richard Klugo, MD,* Thomas Mertz, MD,* and Joseph C. Cerny, MD' There were 116 renal transplants performed on 108 patients RAFT survival after renal transplantation depends upon over a five-year period at Henry Ford Hospital with three the vascular and urinary anastomosis as well as control of major urological complications. The rate of 2.6% compares graft rejection. Numerous factors contribute to good results favorably with that reported in other series. Careful pre in transplantation, among which are immediate function of operative urological evaluation together with technically the homograft, high degree of histocompatibility, the avoid precise ureteroneocystostomy are factors that minimize the ance of excessive immunosuppression, and minimal wound incidence of urological complications. and urological complications. There have been several reportsof urological complications following renal transplantation (See Table). Complication rates as high as 25.7%' have been reported with ureteropyelostomy, while the rates for ureteroneocystos tomy range from 15%^ to less than 1%.' In our review of 116 renal transplants we found three urological complications (2.6%). This rate compares favorably wfth that reported in earlier series and underscores the importance ofthe urolo gist in the work-up and management of the transplant recipient. -
Coders' Desk Reference for ICD-10-PCS Procedures
2 0 2 DESK REFERENCE 1 ICD-10-PCS Procedures ICD-10-PCS for DeskCoders’ Reference Coders’ Desk Reference for ICD-10-PCS Procedures Clinical descriptions with answers to your toughest ICD-10-PCS coding questions Sample 2021 optum360coding.com Contents Illustrations ..................................................................................................................................... xi Introduction .....................................................................................................................................1 ICD-10-PCS Overview ...........................................................................................................................................................1 How to Use Coders’ Desk Reference for ICD-10-PCS Procedures ...................................................................................2 Format ......................................................................................................................................................................................3 ICD-10-PCS Official Guidelines for Coding and Reporting 2020 .........................................................7 Conventions ...........................................................................................................................................................................7 Medical and Surgical Section Guidelines (section 0) ....................................................................................................8 Obstetric Section Guidelines (section -
Vaginal Reconstruction/Sling Urethropexy)
Patient Name: _ Date: _ New Jersey Urologic Institute Dr Betsy Greenleaf DO, FACOOG Pelvic Medicine and Reconstructive Surgery 10Industrial Way East, Suite 101, Eatontown, New Jersey 07724 732-963-9091 Fax: 732-963-9092 Findings: _ Post Operative Instructions (Vaginal Reconstruction/Sling Urethropexy) 1. Activity: May do as much as you feel up to. Your body will let you know when you are doing too much. Don't push yourself, however. Walking is ok and encouraged. If you sit too long you will become stiff and it will make it more difficult to move. Lying around can promote the formation of blood clots that can be life threatening. It is therefore important to move around. If you don't feel like walking, at least move your legs around in bed from time to time. Stairs are ok, just be careful of standing up too quickly and becoming light headed. Sitting still can also increase your risk of pneumonia. In addition to moving around, practice taking deep breaths ( 10 times each every hour or so) to keep your lungs properly aerated. Limitations: Avoid lifting or pushing/pulling any objects heavier than 1Olbs for at least 3 months. For patients with pelvic hernia or prolapse repairs it is recommended not to lift objects heavier than 25 Ibs for life. This may seem unrealistic. Try to put off lifting as long as possible. If you must lift, do not hold your breathe. Blow out as you lift to decrease abdominal and pelvic pressure. Also be aware that if you choose to lift objects heavier than recommended you risk forming another hernia 2. -
Video Surgi Session 2 11:00Am - 1:00Pm Thursday, 29Th October, 2020
Video Surgi Session 2 11:00am - 1:00pm Thursday, 29th October, 2020 41 Holmium Laser Ureterocele Excision with Transurethral Incision of the Prostate Grant R. Pollock MD1, Kalpesh Patel MD2, Joel Funk MD1 1University of Arizona, Department of Urology, Tucson, AZ, USA. 2Arizona Institute of Urology, Tucson, AZ, USA Abstract Objectives: Ureteroceles present a diagnostic and treatment challenge in adults. With an estimated prevalence of 1/500 to 1/4000, it is not uncommon for any urologist to encounter a ureterocele in clinical practice. We present an interesting case of a 53-year-old male with a 20-year history of obstructive voiding symptoms who presented to clinic with urinary retention that was found to be secondary to an orthotopic ureterocele that was prolapsed into the prostatic urethra. The patient underwent holmium laser ureterocele excision with transurethral incision of the prostate with a successful outcome. We present a video demonstrating the technique. Materials and Methods: Preoperative evaluation included a transrectal ultrasound of the prostate which revealed a prostate volume of 20cc. Urodynamics was also performed and pressure flow studies revealed a high-pressure, low flow voiding pattern with a functional detrusor muscle. Cystourethroscopy was performed revealing that an orthotopic ureterocele on the left side was prolapsed into the prostatic urethra and the bladder neck was mildly elevated. Using MOSES technology and laser settings of 30 Hz and 1.5 J, the ureterocele was completely excised and a transurethral incision of the prostate was performed. Results: The patient was discharged home on the day of surgery in stable condition with a Foley catheter in place. -
Summary of Services and Availability (By Location)
UPMC | University of Pittsburgh Medical Center For Reference Only UROLOGY 2013 Summary of Services and Availability (by location) Each location has sufficient space, equipment, staffing and financial resources in place or available in sufficient time as required to support each requested privilege. On an ongoing basis, the organization consistently determines the resources necessary for each requested privilege related to the facility's scope of service. Please review the following Summary of Services and Availability by Location prior to making your selections. If a facility is specifically identified below as NOT having a privilege/service available, you will NOT be considered for that privilege at that individual facility. Any request made that is identified as not available at an individual site will be considered Not Applicable for that site(s), and will be identified as such on your final approved Delineation of Privileges form. “x” means Privilege is Available at that location. “C” means contractual arrangement restricts granting this privilege. “N/A” means Privilege Not Available at that location. Facility Codes: UHOC= UPMC St. Margaret Harmar Outpatient Center Privilege UHOC Core privileges X Consultation Privileges N/A SURGERY OF THE KIDNEY, ADRENAL, URETER, AND BLADDER Biopsy, all techniques X Nephrotomy/pyelotomy/ureterotomy/ cystotomy for X stent placement, stone extraction, drainage abscess, biopsy, fulgeration, insertion of radioactive material Percutaneous nephroscopy, and other percutaneous X catheter techniques Nephrectomy, -
Laparoscopic Ureterolysis Without Omentoplasty in the Management of the Uropathy Secondary to Idiopathic Retroperitoneal Fibrosi
CASE REPORT Laparoscopic Ureterolysis without Omentoplasty in the Management of the Uropathy Secondary to Idiopathic Retroperitoneal Fibrosis Miguel A Bergero1, Patricio A Garcia Marchiñena2, Guillermo Gueglio3, Carlos David4, Fernando Dipatto5, Alberto Jurado6 ABSTRACT Introduction: Obstructive uropathy (OU) secondary to idiopathic retroperitoneal fibrosis (IRF) is an infrequent disease, and the standard treatment has not been established. However, ureterolysis with ureteral intraperitonealization is an effective therapeutic alternative. We present the successful management of OU secondary to an IRF by laparoscopic ureterolysis without omentoplasty (LUWO). Materials and methods: A retrospective descriptive study of 5 patients with IRF treated with LUWO was performed. Results: The average age was 60.4 years. The average creatinine was 3.86 mg/dL. There were no intraoperative or major postoperative complications. In a follow-up period of 31.2 months, all patients are asymptomatic, with an average creatinine level of 1.52 without dialysis requirement. No patients required corticosteroid therapy after surgery. Conclusion: Laparoscopic ureterolysis without omentoplasty is a safe and feasible option to treat the OU caused by IRF that provides good results in the medium-term follow-up, as we describe it in our series of cases. Keywords: Hydronephrosis, Laparoscopy, Retroperitoneal fibrosis, Ureteral obstruction. World Journal of Laparoscopic Surgery (2019): 10.5005/jp-journals-10033-1377 INTRODUCTION 1,4,5Department of Urology, Sanatorio Privado San Geronimo, Santa Fe, Obstructive uropathy (OU) related to idiopathic retroperitoneal Argentina fibrosis (IRF) is a rare disease characterized by retroperitoneal 2,3,6Department of Urology, Hospital Italiano de Buenos Aires, Buenos fibrosis. The pathology has theorized to be an inflammatory Aires, Argentina response to oxidized low-density lipoproteins.1,2 Because IRF has Corresponding Author: Miguel A Bergero, Department of Urology, 3–5 a very low prevalence, no treatments have been standardized.